Story thread · 2 reports / 2 sources
Why BillionToOne Plummeted 36%, Leading A Medtech Sell-Off
investors.com · 5d · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
Medical research stocks took a bath Thursday, helped by BillionToOne's second-quarter report, featuring a beat but no guidance raise. The post Why BillionToOne Plummeted 36%, Leading A Medtech Sell-Off appeared first on Investor's Business Daily .
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.